Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,263,903 papers from all fields of science
Search
Sign In
Create Free Account
Molsidomine
Known as:
Sydnone imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)-
, Morsydomine
, Molsidomin
Expand
A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Narrower (12)
Corpea
Corvaton
Fali-Cor
MTW-Molsidomin
Expand
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Broader (2)
Nitric Oxide Donors
Vasodilator Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
O. Wouters
,
P. Kanavos
,
M. Mckee
Milbank Quarterly
2017
Corpus ID: 24151195
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United…
Expand
Highly Cited
2011
Highly Cited
2011
Nitric Oxide Sustains Long-Term Skeletal Muscle Regeneration by Regulating Fate of Satellite Cells Via Signaling Pathways Requiring Vangl2 and Cyclic GMP
R. Buono
,
C. Vantaggiato
,
+5 authors
E. Clementi
Stem Cells
2011
Corpus ID: 6007707
Satellite cells are myogenic precursors that proliferate, activate, and differentiate on muscle injury to sustain the…
Expand
Highly Cited
2005
Highly Cited
2005
l-arginine improves dystrophic phenotype in mdx mice
V. Voisin
,
C. Sébrié
,
+5 authors
S. Porte
Neurobiology of Disease
2005
Corpus ID: 28030539
Highly Cited
2004
Highly Cited
2004
Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes
Pek Yee Lum
,
Christopher D. Armour
,
+14 authors
Daniel D. Shoemaker
Cell
2004
Corpus ID: 11922219
Highly Cited
1996
Highly Cited
1996
Clinical Pharmacokinetics of Molsidomine
B. Rosenkranz
,
B. Winkelmann
,
M. Parnham
Clinical Pharmacokinetics
1996
Corpus ID: 25730345
SummaryMolsidomine is a prodrug for the formation of nitric oxide (NO). Its pharmacokinetics are characterised by rapid…
Expand
Highly Cited
1996
Highly Cited
1996
Nitric Oxide Donors SIN-1 and SNAP Promote Nonrapid-Eye-Movement Sleep in Rats
L. Kapás
,
J. Krueger
Brain Research Bulletin
1996
Corpus ID: 43174719
Highly Cited
1995
Highly Cited
1995
Pharmacological evidence that nitric oxide can act as an endogenous antipyretic factor in endotoxin-induced fever in rabbits.
A. Gourine
General Pharmacology
1995
Corpus ID: 26107710
Highly Cited
1990
Highly Cited
1990
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
D. Maurice
,
R. Haslam
Molecular Pharmacology
1990
Corpus ID: 40145937
We investigated the roles of cyclic GMP and cyclic AMP in the inhibition of rabbit platelet aggregation and degranulation by two…
Expand
Highly Cited
1988
Highly Cited
1988
Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
R. Gerzer
,
B. Karrenbrock
,
W. Siess
,
J. Heim
Thrombosis Research
1988
Corpus ID: 39562317
Highly Cited
1980
Highly Cited
1980
Molsidomine in the treatment of patients with angina pectoris.
Majid Pa
,
P. deFeyter
,
E. E. V. D. Wall
,
Rafik Wardeh
,
J. P. Roos
New England Journal of Medicine
1980
Corpus ID: 27873048
Molsidomine, a new long-acting vasodilator, was administered intravenously (0.03 mg per kilogram of body weight) to two groups of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE